7 Nov 2013 [Press release]

GenoFlow DR-MTB is now CE marked

Thinking about the importance of a fast and accurate diagnosis of tuberculosis, DiagCor's GenoFlow DR-MTB has been CE marked. Currently more than 8 million cases of tuberculosis are known worldwide and nearly 1 million people die due to this infection each year.

This high mortality is strongly related to the failure in the treatment compliance. According to the WHO, drug-resistant Tuberculosis is virtually found in all countries which imposes a major obstacle in the run to control and treat this infection.

Failure to completely cure tuberculosis due to drug resistance, vastly increases the chances of disease out-spread.

The GenoFlow DR-MTB covers the major mutation points found in most of drug resistance cases related to isoniazid and rifampicin.

"Getting our DR-MTB kit CE marked puts us closer in the fight to eradicate this disease and contribute to the wellbeing of our community". Dr. Tam, CEO of DiagCor.